Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 18 studies | 38% ± 15% | |
oligodendrocyte precursor cell | 3 studies | 20% ± 4% | |
ependymal cell | 3 studies | 51% ± 15% | |
astrocyte | 3 studies | 31% ± 12% |
Insufficient scRNA-seq data for expression of RGS22 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 97% | 201.21 | 443 / 459 | 53% | 4.47 | 587 / 1118 |
ovary | 100% | 1561.16 | 180 / 180 | 32% | 0.91 | 138 / 430 |
prostate | 99% | 242.42 | 243 / 245 | 27% | 0.40 | 135 / 502 |
lung | 96% | 274.44 | 556 / 578 | 18% | 0.56 | 211 / 1155 |
uterus | 99% | 518.72 | 169 / 170 | 15% | 0.60 | 69 / 459 |
brain | 78% | 137.92 | 2069 / 2642 | 29% | 1.33 | 202 / 705 |
adipose | 99% | 226.80 | 1187 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 34% | 24.80 | 89 / 258 | 63% | 2.80 | 146 / 230 |
bladder | 90% | 140.71 | 19 / 21 | 2% | 0.05 | 11 / 504 |
skin | 68% | 110.14 | 1239 / 1809 | 9% | 0.24 | 41 / 472 |
blood vessel | 76% | 64.54 | 1012 / 1335 | 0% | 0 | 0 / 0 |
intestine | 56% | 49.13 | 543 / 966 | 2% | 0.04 | 8 / 527 |
heart | 41% | 31.69 | 353 / 861 | 0% | 0 | 0 / 0 |
esophagus | 39% | 28.13 | 569 / 1445 | 1% | 0.03 | 2 / 183 |
thymus | 39% | 26.38 | 252 / 653 | 1% | 0.02 | 7 / 605 |
stomach | 27% | 19.04 | 98 / 359 | 3% | 0.10 | 10 / 286 |
kidney | 22% | 13.52 | 20 / 89 | 8% | 0.29 | 74 / 901 |
pancreas | 8% | 3.91 | 25 / 328 | 13% | 0.26 | 24 / 178 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.08 | 1 / 29 |
muscle | 3% | 3.45 | 27 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 2% | 2.09 | 18 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.01 | 1 / 80 |
liver | 0% | 0.53 | 1 / 226 | 0% | 0.02 | 2 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0009968 | Biological process | negative regulation of signal transduction |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0001650 | Cellular component | fibrillar center |
GO_0005634 | Cellular component | nucleus |
GO_0001965 | Molecular function | G-protein alpha-subunit binding |
Gene name | RGS22 |
Protein name | Regulator of G protein signaling 22 Regulator of G protein signaling 22 (Regulator of G-protein signalling 22, isoform CRA_c) Regulator of G-protein signaling 22 (RGS22) |
Synonyms | hCG_15692 |
Description | FUNCTION: Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits thereby driving them into their inactive GDP-bound form. . |
Accessions | ENST00000523437.5 [Q8NE09-3] E5RJ23 ENST00000519092.5 H0YBV2 ENST00000360863.11 [Q8NE09-1] ENST00000519408.5 E5RGJ7 ENST00000517828.5 ENST00000517843.5 Q8NE09 ENST00000520117.5 ENST00000523287.5 E5RFV6 ENST00000519725.5 [Q8NE09-2] G3V112 E5RHE4 |